Literature DB >> 11264303

Neurofilaments are nonessential to the pathogenesis of toxicant-induced axonal degeneration.

J D Stone1, A P Peterson, J Eyer, T G Oblak, D W Sickles.   

Abstract

Axonal neurofilament (NF) accumulations occur before development of symptoms and before other pathological changes among idiopathic neurodegenerative diseases and toxic neuropathies, suggesting a cause-effect relationship. The dependence of symptoms and axonal degeneration on neurofilament accumulation has been tested here in a transgenic mouse model (Eyer and Peterson, 1994) lacking axonal NFs and using two prototypic toxicant models. Chronic acrylamide (ACR) or 2,5-hexanedione exposure resulted in progressive and cumulative increases in sensorimotor deficits. Neurobehavioral tests demonstrated similar expression of neurotoxicity in transgenic (T) mice and their nontransgenic (NT) littermates (containing normal numbers of axonal NFs). Axonal lesions were frequently observed after exposure to either toxicant. Quantitation of ACR-induced lesions demonstrated the distal location of pathology and equal susceptibility of T and NT axons. We conclude that axonal NFs have no effect on neurotoxicity and the pattern of pathology in these mammalian toxic neuropathies. These results also suggest that the role of neurofilament accumulation in the pathogenesis of neurodegenerative diseases requires careful evaluation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11264303      PMCID: PMC6762395     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  53 in total

1.  Neurofilaments are non-essential elements of toxicant-induced reductions in fast axonal transport: pulse labeling in CNS neurons.

Authors:  J D Stone; A P Peterson; J Eyer; D W Sickles
Journal:  Neurotoxicology       Date:  2000-08       Impact factor: 4.294

2.  The crayfish neuronal cytoskeleton: an investigation of proteins having neurofilament-like immunoreactivity.

Authors:  D J Weaver; T A Viancour
Journal:  Brain Res       Date:  1991-03-22       Impact factor: 3.252

3.  Peripheral neuropathy in rats produced by acrylamide.

Authors:  P M Fullerton; J M Barnes
Journal:  Br J Ind Med       Date:  1966-07

4.  Observations on the effects on rats of compounds related to acrylamide.

Authors:  J M Barnes
Journal:  Br J Ind Med       Date:  1970-04

5.  Neurotoxic effects of 2,5-hexanedione on normal and neurofilament-deficient quail.

Authors:  T Hirai; M Mizutani; T Kimura; K Ochiai; T Umemura; C Itakura
Journal:  Toxicol Pathol       Date:  1999 May-Jun       Impact factor: 1.902

6.  Covalent binding of a neurotoxic n-hexane metabolite: conversion of primary amines to substituted pyrrole adducts by 2,5-hexanedione.

Authors:  A P DeCaprio; E J Olajos; P Weber
Journal:  Toxicol Appl Pharmacol       Date:  1982-09-30       Impact factor: 4.219

7.  Toxic neurofilamentous axonopathies and fast anterograde axonal transport. I. The effects of single doses of acrylamide on the rate and capacity of transport.

Authors:  D W Sickles
Journal:  Neurotoxicology       Date:  1989       Impact factor: 4.294

8.  Toxic neurofilamentous axonopathies and fast anterograde axonal transport. III. Recovery from single injections and multiple dosing effects of acrylamide and 2,5-hexanedione.

Authors:  D W Sickles
Journal:  Toxicol Appl Pharmacol       Date:  1991-05       Impact factor: 4.219

9.  Slow axonal transport of neurofilament proteins: impairment of beta,beta'-iminodipropionitrile administration.

Authors:  J W Griffin; P N Hoffman; A W Clark; P T Carroll; D L Price
Journal:  Science       Date:  1978-11-10       Impact factor: 47.728

10.  Acrylamide alters oxidative enzyme activity in rat motoneurons.

Authors:  D W Sickles; B D Goldstein
Journal:  Toxicol Lett       Date:  1985-08       Impact factor: 4.372

View more
  7 in total

Review 1.  Review of the multiple aspects of neurofilament functions, and their possible contribution to neurodegeneration.

Authors:  Rodolphe Perrot; Raphael Berges; Arnaud Bocquet; Joel Eyer
Journal:  Mol Neurobiol       Date:  2008-07-23       Impact factor: 5.590

Review 2.  Toxic Peripheral Neuropathies: Agents and Mechanisms.

Authors:  William M Valentine
Journal:  Toxicol Pathol       Date:  2019-06-10       Impact factor: 1.902

3.  Gamma-diketone axonopathy: analyses of cytoskeletal motors and highways in CNS myelinated axons.

Authors:  Lihai Zhang; Terrence Gavin; Anthony P DeCaprio; Richard M LoPachin
Journal:  Toxicol Sci       Date:  2010-06-16       Impact factor: 4.849

4.  Spatio-temporal changes in neurofilament proteins immunoreactivity following kainate-induced cerebellar lesion in rats.

Authors:  I Milenkovic; R Filipovic; N Nedeljkovic; S Pekovic; M Culic; L Rakic; M Stojiljkovic
Journal:  Cell Mol Neurobiol       Date:  2004-06       Impact factor: 5.046

5.  Probing mechanisms of axonopathy. Part I: Protein targets of 1,2-diacetylbenzene, the neurotoxic metabolite of aromatic solvent 1,2-diethylbenzene.

Authors:  Desire Tshala-Katumbay; Victor Monterroso; Robert Kayton; Michael Lasarev; Mohammad Sabri; Peter Spencer
Journal:  Toxicol Sci       Date:  2008-05-22       Impact factor: 4.849

Review 6.  The Role of Protein Adduction in Toxic Neuropathies of Exogenous and Endogenous Origin.

Authors:  Peter S Spencer; Xiao Chen
Journal:  Toxics       Date:  2021-04-29

7.  A hereditary spastic paraplegia mutation in kinesin-1A/KIF5A disrupts neurofilament transport.

Authors:  Lina Wang; Anthony Brown
Journal:  Mol Neurodegener       Date:  2010-11-18       Impact factor: 14.195

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.